TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
TELA Bio, Inc. (NASDAQ: TELA), a leader in soft-tissue reconstruction solutions, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The company's management team is set to present on August 14th, 2024, at 10:30 am ET. This event provides an opportunity for TELA Bio to showcase its innovative medical technology and growth strategies to investors and industry professionals.
Interested parties can access both the live presentation and archived webcast through TELA Bio's investor relations website at ir.telabio.com. This participation underscores TELA Bio's commitment to engaging with the investment community and highlights its position in the rapidly evolving medical technology sector.
TELA Bio, Inc. (NASDAQ: TELA), un leader nelle soluzioni per la ricostruzione dei tessuti molli, ha annunciato la sua partecipazione alla 44a Conferenza Annuale sulla Crescita di Canaccord Genuity. Il team di gestione dell'azienda presenterà il 14 agosto 2024, alle 10:30 ET. Questo evento offre a TELA Bio l'opportunità di mostrare la sua tecnologia medica innovativa e le strategie di crescita a investitori e professionisti del settore.
Le parti interessate possono accedere sia alla presentazione dal vivo che al webcast archiviato tramite il sito web delle relazioni con gli investitori di TELA Bio all'indirizzo ir.telabio.com. Questa partecipazione sottolinea l'impegno di TELA Bio nel coinvolgere la comunità degli investitori e mette in evidenza la sua posizione nel settore della tecnologia medica in rapida evoluzione.
TELA Bio, Inc. (NASDAQ: TELA), un líder en soluciones de reconstrucción de tejidos blandos, ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity. El equipo directivo de la empresa presentará el 14 de agosto de 2024, a las 10:30 a.m. ET. Este evento brinda a TELA Bio la oportunidad de mostrar su tecnología médica innovadora y sus estrategias de crecimiento a inversores y profesionales de la industria.
Las partes interesadas pueden acceder tanto a la presentación en vivo como al webcast archivado a través del sitio web de relaciones con inversores de TELA Bio en ir.telabio.com. Esta participación subraya el compromiso de TELA Bio de involucrarse con la comunidad inversora y destaca su posición en el sector de la tecnología médica en rápida evolución.
TELA Bio, Inc. (NASDAQ: TELA)는 연부 조직 재건 솔루션의 선두주자로서 캐넌코드 제너리티 제44회 연례 성장 컨퍼런스에 참여한다고 발표했습니다. 회사의 관리 팀은 2024년 8월 14일 오전 10시 30분 ET에 발표할 예정입니다. 이 이벤트는 TELA Bio가 투자자와 업계 전문가들에게 혁신적인 의료 기술과 성장 전략을 선보일 기회를 제공합니다.
관심 있는 분들은 TELA Bio의 투자자 관계 웹사이트 ir.telabio.com를 통해 실시간 발표와 보관된 웹캐스트에 접근할 수 있습니다. 이번 참여는 TELA Bio가 투자 커뮤니티와 소통하겠다는 의지를 강조하며, 빠르게 발전하는 의료 기술 분야에서의 입지를 부각시킵니다.
TELA Bio, Inc. (NASDAQ: TELA), un leader dans les solutions de reconstruction des tissus mous, a annoncé sa participation à la 44ème Conférence Annuelle de Croissance de Canaccord Genuity. L'équipe de direction de l'entreprise présentera le 14 août 2024 à 10h30 ET. Cet événement offre à TELA Bio l'opportunité de mettre en avant sa technologie médicale innovante et ses stratégies de croissance auprès des investisseurs et des professionnels de l'industrie.
Les parties intéressées peuvent accéder à la fois à la présentation en direct et à l'enregistrement du webinaire via le site web des relations avec les investisseurs de TELA Bio à l'adresse ir.telabio.com. Cette participation souligne l'engagement de TELA Bio à interagir avec la communauté des investisseurs et met en lumière sa position dans le secteur de la technologie médicale en rapide évolution.
TELA Bio, Inc. (NASDAQ: TELA), ein führendes Unternehmen im Bereich der Rekonstruktionslösungen für Weichgewebe, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity bekannt gegeben. Das Management-Team des Unternehmens wird am 14. August 2024 um 10:30 Uhr ET präsentieren. Diese Veranstaltung bietet TELA Bio die Möglichkeit, seine innovative Medizintechnologie und Wachstumsstrategien Investoren und Fachleuten der Branche vorzustellen.
Interessierte Parteien können sowohl die Live-Präsentation als auch das archivierte Webcast über die Investor Relations-Website von TELA Bio unter ir.telabio.com abrufen. Diese Teilnahme unterstreicht das Engagement von TELA Bio, mit der Investoren-Community in Kontakt zu treten, und hebt die Position des Unternehmens im schnell entwickelnden Medizintechnik-Sektor hervor.
- None.
- None.
MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference.
TELA’s management is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference at 10:30 am ET on August 14th, 2024. Interested parties can access the live and archived webcast at ir.telabio.com.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Investor Contact
Greg Chodaczek
347-620-7010
ir@telabio.com
FAQ
When is TELA Bio presenting at the Canaccord Genuity 44th Annual Growth Conference?
How can investors access TELA Bio's presentation at the Canaccord Genuity conference?
What is TELA Bio's focus as a medical technology company?
What stock exchange is TELA Bio listed on?
